Received May 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EW0172 | — |
Diplopia; This is a spontaneous report received from a Consumer or other non HCP. A 49-year-old male patient received BNT162b2 (BNT162B2), on 19Aug2021 at 08:30 as dose 2, single (Lot number: EW0172) at the age of 46 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Contrast dye" (unspecified if ongoing), notes: Known allergies: Contrast dye. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for Covid-19 Immunization. The following information was reported: DIPLOPIA (disability) with onset 10Aug2024, outcome "not recovered". Therapeutic measures were taken as a result of diplopia.
Medical History/Concurrent Conditions: Contrast media allergy (Known allergies: Contrast dye)